4Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA,2013,310(9):948-959. DOI: 10.1001/ jama.2013.168118.
5Yang W, Ji Q, Zhu D, et al. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs[J]. Diabetes Care,2008,31(5):852-856. DOI: 10.2337/ dc07-1992.
6Zafar MI, Ai X, Shafqat RA, et al. Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes[J]. Ther Clin Risk Manag,2015, 11:27-32. DOI: 10.2147/TCRM.S75602.
7Yang W, Xu X, Liu X, et al. Treat-to-target comparison between once daily biphasic insulin aspart 30 and insulin glargine in Chinese and Japanese insulin- na'l've subjects with type 2 diabetes[J]. Curr Med Res Opin,2013, 29(12): 1599- 1608. DOI: 10.1185/03007995.2013.838155.
8Kalra S, Plata-Que T, Kumar D, et al. Initiation with once-daily BIAsp 30 results in superior outcome compared to insulin glargine in Asians with type 2 diabetes inadequately controlledby oral anti-diabetic drugs[J]. Diabetes Res Clin Pract, 2010, 88 (3):282-288. DOI: 10.1016/j.diabres.2010.03.004.
9Yang W, Zhu L, Meng 15, et al. ubject-drtven titration oI biphasie insulin aspart 30 twice daily is non-inferior to investigator-driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: a randomized, open-label, parallel-group, mul[J]. J Diabetes Investig, 201512015-5-25]. http://onlinelibrary.wiley. com/DOI/10.1111/jdi. 12364/pdf. [published online ahead of print].
10Davidson JA, Liebl A, Christiansen JS, et al. Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis[J]. Clin Ther, 2009, 31(8): 1641-1651. DOI: 10.1016/j.clinthera.2009.08.011.
